Differential pulsatile secretagogue control of GH secretion in healthy men.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Physiology. Regulatory Integrative and Comparative Physiology

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpregu.00069.2013PMID 23485864PMCID PMC3652074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.

  2012cited by this paper
• Lifetime Regulation of Growth Hormone (GH) Secretion

  2012cited by this paper
• Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.

  2010cited by this paper
• Estrogen Receptors and Signaling Pathways in Lactotropes and Somatotropes

  2010cited by this paper
• Assessment of ghrelin, GHS-R, GH, and neurohormones in human fetal pituitary glands and central nervous system: an immunohistochemical study.

  2010cited by this paper
• Motivations and methods for analyzing pulsatile hormone secretion.

  2008cited by this paper
• Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density

  2008cited by this paper
• The Role of Growth Hormone Secretagogues and Ghrelin in Feeding and Body Composition

  2007cited by this paper
• Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition.

  2006cited by this paper
• Estrogen and the Brain: Beyond ER‐α, ER‐β, and 17β‐Estradiol

  2005cited by this paper
• Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol.

  2005cited by this paper
• Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood.

  2005cited by this paper
• Estrogen and the brain: beyond ER-α and ER-β

  2004cited by this paper
• Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement.

  2004cited by this paper
• Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.

  2004cited by this paper
• Physiological control of pituitary hormone secretory-burst mass, frequency, and waveform: a statistical formulation and analysis.

  2003cited by this paper
• Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.

  2003cited by this paper
• Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity.

  2002cited by this paper
• Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.

  2002cited by this paper
• The GH‐releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans

  2002cited by this paper
• Estrogen receptor (ER)alpha, but not ERbeta, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus.

  2001cited by this paper
• Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.

  2001cited by this paper
• Regulation of the pituitary somatotroph cell by GHRH and its receptor.

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Genomic Structure and Transcriptional Regulation of the Human Growth Hormone Secretagogue Receptor*

  2000cited by this paper
• Secretagogues and the somatotrope: signaling and proliferation.

  2000cited by this paper
• Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.

  2000cited by this paper
• Neuroendocrine control of growth hormone secretion.

  1999cited by this paper
• Age-related Variations in the Neuroendocrine Control, More Than Impaired Receptor Sensitivity, Cause The Reduction in the GH-releasing Activity of GHRPs in Human Aging

  1998cited by this paper
• Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

  1998cited by this paper
• Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries.

  1998cited by this paper
• The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.

  1996cited by this paper
• Temporal structure of in vivo growth hormone secretory events in humans.

  1991cited by this paper
• ARGININE POTENTIATES THE GHRH‐ BUT NOT THE PYRIDOSTIGMINE‐INDUCED GH SECRETION IN NORMAL SHORT CHILDREN. FURTHER EVIDENCE FOR A SOMATOSTATIN SUPPRESSING EFFECT OF ARGININE

  1990cited by this paper
• Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons.

  1990cited by this paper
• Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin.

  1989cited by this paper
• Pituitary immediate release pools of growth hormone and prolactin are preferentially refilled by new rather than stored hormone.

  1989cited by this paper
• Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.

  1988cited by this paper
• PLASMA IMMUNOREACTIVE GHRH AND SERUM GH CONCENTRATIONS FOLLOWING PULSATILE GHRH 1‐40 ADMINISTRATION IN GH DEFICIENT CHILDREN

  1987cited by this paper
• The appropriateness of analysis of variance and multiple-comparison procedures.

  1983cited by this paper
• The appropriateness of analysis of variance and multiple-comparison procedures.

  1983cited by this paper
• Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.

  1979cited by this paper
• Latin squares and related designs.

  1962cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatura

  year unknowncited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Pharmacokinetics and Pharmacodynamics of Growth Hormone-Releasing Peptide-2: A Phase I Study in Children*

  year unknowncited by this paper

• Somatotropic axis

  2019cites this paper
• Multipathway modulation of exercise and glucose stress effects upon GH secretion in healthy men.

  2015cites this paper
• Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.

  2014cites this paper
• Effect of sleep deprivation on exercise-induced growth hormone release

  2014cites this paper